288 participants
Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy: a Randomized, Double-blinded, Placebo-Controlled Trial
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2026-05-01
- Completion:
- 2028-12-01
Conditions
- IgA Nephropathy (IgAN)
Interventions
- DRUG
No Results Yet